Basic information
Biomarker: Hsa-miR-155
Histology type: endometrial carcinoma
Cohort characteristics
Country: China
Region: Hunan
Study type: prospective study
Followed up time :
Subgroup 1 name : EC
Subgroup 1 number: 44
Subgroup 2 name: Healthy controls
Subgroup 2 number: 12
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 56 | EC | 44 | health | 12 |
Sample information
Description: Hsa-miR-155 may play an important role in the proliferation, and metastasis of endometrial cancer, which may be a indicator in the diagnosis and prognosis of endometrial cancer and may be used as a predictive biomarker.
Sample type : serum
Sample method: Real time quantity PCR
Disease information
Related information
HGNC miRNA approved symbol: MIR155
HGNC miRNA approved name: microRNA 155
HGNC miRNA locus type: RNA, micro
HGNC miRNA symbol status: Approved
HGNC miRNA ID: HGNC:31542
HGNC miRNA link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:31542
Stem loop sequence symbol: hsa-mir-155
Stem loop sequence accession: MI0000681
Stem loop sequence gene family: MIPF0000157
Stem loop sequence annotation confidence: high
Mature sequence symbol: hsa-miR-155-5p$ hsa-miR-155-3p
Mature sequence accession: MIMAT0000646$ MIMAT0004658
Previous IDs: hsa-miR-155$hsa-miR-155*
Evidence: experimental; cloned [PMID:15325244,PMID:17604727,PMID:17616659,PMID:17989717],experimental; cloned [PMID:17604727]
miRBase link: https://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000681
